NASDAQ:HOWL
Werewolf Therapeutics, Inc.
- Stock
Last Close
2.22
30/08 20:00
Market Cap
95.60M
Beta: 0.21
Volume Today
148.15K
Avg: 55.98K
PE Ratio
−6.10
PFCF: −5.35
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 1 - | |||||
average payables | 827K - | 1.53M 84.89% | 1.63M 6.54% | 1.28M 21.52% | ||
average receivables | 3.46M - | 4.14M 19.49% | ||||
book value per share | -2.71 - | -5.78 113.39% | 8.28 243.20% | 4.24 48.80% | 0.00 99.93% | |
capex per share | -0.03 - | -0.06 110.53% | -0.03 56.77% | -0.13 363.61% | -0.00 99.98% | |
capex to depreciation | -10.64 - | -3.73 64.91% | -2.31 38.24% | -3.27 41.87% | -0.44 86.67% | |
capex to operating cash flow | 0.03 - | 0.03 7.86% | 0.01 61.37% | 0.09 665.82% | 0.02 73.49% | |
capex to revenue | -0.22 - | -0.04 82.49% | ||||
cash per share | 1.99 - | 10.32 417.27% | 8.54 17.28% | 4.48 47.51% | 0.00 99.90% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | 154.18 - | 24.71 83.97% | ||||
debt to assets | 0.14 - | 0.03 81.78% | 0.09 231.45% | 0.09 4.88% | 0.07 21.35% | |
debt to equity | -0.13 - | -0.05 62.04% | 0.10 309.21% | 0.12 17.10% | 0.11 5.75% | |
dividend yield | ||||||
earnings yield | -0.08 - | -0.10 35.93% | -0.23 118.90% | -0.87 284.88% | -0.00 99.97% | |
enterprise value | 129.67M - | 54.40M 58.05% | 77.93M 43.25% | -55.46M 171.17% | 137.45B 247,942.58% | |
enterprise value over ebitda | -13.59 - | -2.44 82.01% | -1.56 36.35% | 0.99 163.59% | -3.68K 371,890.41% | |
ev to operating cash flow | -13.59 - | -2.92 78.51% | -1.82 37.78% | 1.37 175.16% | -4.21K 308,618.88% | |
ev to sales | -3.38 - | 6.89K 203,924.21% | ||||
free cash flow per share | -1.09 - | -2.14 95.60% | -2.35 9.90% | -1.53 34.83% | -0.00 99.94% | |
free cash flow yield | -0.07 - | -0.13 95.60% | -0.20 48.57% | -0.75 278.60% | -0.00 99.97% | |
graham net net | -3.13 - | -6.21 98.28% | 7.10 214.40% | 3.35 52.87% | 0.00 99.92% | |
graham number | 8.64 - | 14.72 70.31% | 22.41 52.28% | 13.05 41.76% | 0.01 99.93% | |
income quality | 0.93 - | 1.24 32.99% | 0.86 30.73% | 0.75 12.05% | 0.87 15.68% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | 50.78 - | 11.90 76.55% | ||||
interest debt per share | 0.35 - | 0.28 19.00% | 0.85 199.59% | 0.47 44.56% | 0.00 99.94% | |
inventory turnover | ||||||
invested capital | -0.13 - | -0.05 62.04% | 0.10 309.21% | 0.12 17.10% | 0.11 5.75% | |
market cap | 144.43M - | 144.43M 0% | 219.80M 52.19% | 59.17M 73.08% | 137.60B 232,438.41% | |
net current asset value | -27.92M - | -55.35M 98.23% | 134.60M 343.20% | 102.29M 24.01% | 74.91M 26.77% | |
net debt to ebitda | 1.55 - | 4.05 161.52% | 2.83 29.98% | 2.04 27.80% | 3.82 86.83% | |
net income per share | -1.23 - | -1.67 35.93% | -2.70 61.93% | -1.79 33.75% | -0.00 99.94% | |
operating cash flow per share | -1.06 - | -2.08 95.18% | -2.32 11.91% | -1.41 39.46% | -0.00 99.93% | |
payables turnover | ||||||
receivables turnover | 2.37 - | 14.77 524.01% | ||||
research and ddevelopement to revenue | 3.28 - | 2.09 36.09% | ||||
return on tangible assets | -0.51 - | -0.15 69.43% | -0.28 79.15% | -0.32 15.90% | -0.21 33.58% | |
revenue per share | 0.57 - | 0.00 99.90% | ||||
roe | 0.45 - | 0.29 36.30% | -0.33 213.08% | -0.42 29.40% | -0.34 20.40% | |
roic | 0.59 - | 0.48 19.51% | -0.27 156.94% | -0.35 30.72% | -0.27 22.73% | |
sales general and administrative to revenue | 1.14 - | 0.94 17.87% | ||||
shareholders equity per share | -2.71 - | -5.78 113.39% | 8.28 243.20% | 4.24 48.80% | 0.00 99.93% | |
stock based compensation to revenue | 0.45 - | 0.40 11.00% | ||||
tangible asset value | -24.30M - | -51.86M 113.39% | 152.79M 394.60% | 122.34M 19.93% | 111.37M 8.96% | |
tangible book value per share | -2.71 - | -5.78 113.39% | 8.28 243.20% | 4.24 48.80% | 0.00 99.93% | |
working capital | 16.02M - | 87.63M 447.04% | 149.19M 70.25% | 116.21M 22.11% | 118.99M 2.39% |
All numbers in USD (except ratios and percentages)